Winter Quarterly

Upcoming Events & Seminars

Jan January 27 Tue 2015

Frontiers in Cardiovascular Science
"Proteomics of Coronary Heart Disease: Development of Risk Prediction Models and a Candidate Protective Protein for Heart Failure "
Richard Lawn, MD

CVI Consulting Professor
Noon @ LKSC LK120

Jan January 28 Wed 2015

"Screening ECG Programs in Adolescents"
Anne Dubin, MD
Noon @ Falk Library

Feb February 04 Wed 2015

Faculty Club
Stanley Rockson, MD
4:30 pm @ Lorry Lokey (SIM1) G1161

May May 08-09 Fri-Sat 2015

Featured Event

May May 22 Fri 2015

Cardiac Engineering Symposium
Location: Clark Center 



Follow Us

Contact Us

Stanford Cardiovascular Institute
265 Campus Drive
Stanford, CA 94305
(650) 723-9126

Emerging Stories

CVI T32 Training Grant on "Mechanism and Innovation in Vascular Disease" renewed till June 2020. Congratulations to Drs. Ronald Dalman and Phil Tsao.

For this year’s Retreat, we asked our selected members to dig deep into the past and project the future of their specialties. Whether it’s clinical science, imaging, stem cells, big data, women’s health or biomaterials and devices, the goal is to propel research that ensures a future in which we minimize damaging one of nature’s most delicate organs.

In his work, Gambhir, who has particular interest in cancer biology and gene therapy, combines advances in molecular and cell biology with those in biomedical imaging.

Circulation: "Prasugrel Plus Aspirin Beyond 12 Months Is Associated With Improved Outcomes After Taxus Liberte Paclitaxel-Eluting Coronary Stent Placement"

NEJM: "Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents"

Paper title: Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity

We are please to announce the recipients of the December 2014 CVI Postdoctoral Fellow Travel Awards. We encourage postdoctoral scholars to attend conferences and exchange ideas!

CVI and Stanford have a strong showing at the AHA this year. Visit and support your colleagues at the Nov. 15-19, 2014, in Chicago, IL by checking out some of their abstracts and presentations. 

This summit will bring together faculty and participants involved in the areas of arrhythmia mechanisms, diagnosis, and management to participate in topics devoted to cutting edge research and therapeutic innovation. A diverse range of topics will permit clinicians, basic scientists, biomedical engineers and outcomes experts to participate. 

The 2014 FH Global Summit will focus on “Bridging the Gaps” in care for those living with familial hypercholesterolemia (FH). The largest issues worldwide continue to be the underdiagnosis of FH and the underappreciation of the effects of FH by individuals, families, and healthcare providers. Perhaps even more importantly, cascade (family-based) screening is not performed, potentially leading to catastrophic outcomes. The FH Foundation is deeply committed to strategically addressing these issues.

Dr. Hlatky is a cardiologist with major research interests in clinical trials, clinical research methods, outcomes research, and comparative effectiveness research. He has participated in many large, multicenter randomized clinical trials, including studies of coronary revascularization, treatment of acute myocardial infarction, hormone therapy to prevent cardiovascular disease, and management of life-threatening ventricular arrhythmias.

Kobilka is the Helene Irwin Fagan Chair in Cardiology and a professor of molecular and cellular physiology. He shared the 2012 Nobel Prize in Chemistry for his work on understanding the structure and function of G-protein-coupled receptors, a large family of receptors that sense molecules outside the cell and convey chemical messages from those molecules into the cell’s interior.




The CVI would like to warmly congratulate Dr. Sean M. Wu, Assistant Professor of Medicine, Division of Cardiovascular Medicine, Department of Medicine, and Institute for Stem Cell Biology and Regenerative Medicine, for receiving the NIH Director’s Pioneer Award.

Member Resources

Biomarker Discovery Technology Series

First Monday of every month
Next session: Febuary 2, 2014
Alan HB Wu, PhD
"Use of High Resolution Mass Spectrometry for Integrated Analysis within Clinical and Environmental Toxicology"
Register here

CVI Report

Cardiovascular Institute Leadership

Joseph C. Wu, MD, PhD

  • Director, Stanford Cardiovascular Institute
  • Professor, Department of Medicine/Cardiology & Radiology

Robert A. Harrington, MD

  • Director of Clinical Investigation, Stanford Cardiovascular Institute
  • Arthur L. Bloomfield Professor of Medicine
  • Chair, Department of Medicine 

Beating cells growing in a culture dish

Generous donations support research and education dedicated to understanding the healthy human heart and heart disease. Implementing research into patient-care is Stanford Medicine.

High School Students!
Stanford Institutes of Medicine Summer Research Program
Application Deadline: February 22nd, 2015.

Cardiovascular Links @ Stanford